Please login to the form below

Not currently logged in

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

LinkedIn adds a pharma 'influencer'

Pfizer CEO Ian Read joins the likes of Bill Gates and Richard Branson in writing for the social network
LinkedIn Pfizer Ian Read

LinkedIn this week added the first pharma voice to its Influencer articles with a post by Pfizer CEO Ian Read.  

The articles have been contributed from business leaders such as Bill Gates and Richard Branson since October 2012 as part of moves towards publishing that have also seen it launch the LinkedIn Today news service.  

Read's 'You gain respect in drops, but can lose it in gallons' takes aim at the importance of a pharma company's reputation and just one day after publication had amassed more than 8,500 views.  

In terms of engagement the article is doing well too, having so far attracted more than 1,200 shares and 66 comments on LinkedIn, not to mention 45 tweets and 112 Facebook 'likes'.  

LinkedIn influencers

The Pfizer CEO's debut as an Influencer, one of more than 50 names added, including the CEOs of Nissan and Morgan Stanley, comes as LinkedIn starts opening up its publishing platform to its rank and file members.  

Members will be able to share long-form posts to their LinkedIn profile and, in a Facebook-like move, they can be followed by LinkedIn members with which they are not connected.

21st February 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...